195 related articles for article (PubMed ID: 35379164)
1. Vesicular Approach Review on Nanocarriers bearing Curcumin and Applications.
Upadhyay P; Singh D; Upadhyay S
Recent Adv Drug Deliv Formul; 2022 Apr; ():. PubMed ID: 35379164
[TBL] [Abstract][Full Text] [Related]
2. Targeting Cancer using Curcumin Encapsulated Vesicular Drug Delivery Systems.
Hardwick J; Taylor J; Mehta M; Satija S; Paudel KR; Hansbro PM; Chellappan DK; Bebawy M; Dua K
Curr Pharm Des; 2021; 27(1):2-14. PubMed ID: 32723255
[TBL] [Abstract][Full Text] [Related]
3. Proniosomes derived niosomes: recent advancements in drug delivery and targeting.
Khatoon M; Shah KU; Din FU; Shah SU; Rehman AU; Dilawar N; Khan AN
Drug Deliv; 2017; 24(sup1):56-69. PubMed ID: 29130758
[TBL] [Abstract][Full Text] [Related]
4. Ethosomes and Transfersomes: Principles, Perspectives and Practices.
Garg V; Singh H; Bimbrawh S; Singh SK; Gulati M; Vaidya Y; Kaur P
Curr Drug Deliv; 2017; 14(5):613-633. PubMed ID: 27199229
[TBL] [Abstract][Full Text] [Related]
5. Vesicular system: Versatile carrier for transdermal delivery of bioactives.
Singh D; Pradhan M; Nag M; Singh MR
Artif Cells Nanomed Biotechnol; 2015; 43(4):282-90. PubMed ID: 24564350
[TBL] [Abstract][Full Text] [Related]
6. Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.
Verma P; Prajapati SK; Yadav R; Senyschyn D; Shea PR; Trevaskis NL
Mol Pharm; 2016 Nov; 13(11):3688-3699. PubMed ID: 27632682
[TBL] [Abstract][Full Text] [Related]
7. Review on Different Vesicular Drug Delivery Systems (VDDSs) and Their Applications.
Alenzi AM; Albalawi SA; Alghamdi SG; Albalawi RF; Albalawi HS; Qushawy M
Recent Pat Nanotechnol; 2023; 17(1):18-32. PubMed ID: 35227188
[TBL] [Abstract][Full Text] [Related]
8. Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus.
Mbah CC; Builders PF; Attama AA
Expert Opin Drug Deliv; 2014 Jan; 11(1):45-59. PubMed ID: 24294974
[TBL] [Abstract][Full Text] [Related]
9. Proniosomes: the effective and efficient drug-carrier system.
Mittal S; Chaudhary A; Chaudhary A; Kumar A
Ther Deliv; 2020 Feb; 11(2):125-137. PubMed ID: 31937205
[TBL] [Abstract][Full Text] [Related]
10. A review on novel vesicular drug delivery: proniosomes.
Yasam VR; Jakki SL; Natarajan J; Kuppusamy G
Drug Deliv; 2014 Jun; 21(4):243-9. PubMed ID: 24128089
[TBL] [Abstract][Full Text] [Related]
11. Provesicles as novel drug delivery systems.
Bayindir ZS; Yuksel N
Curr Pharm Biotechnol; 2015; 16(4):344-64. PubMed ID: 25658383
[TBL] [Abstract][Full Text] [Related]
12. Prodrugs, phospholipids and vesicular delivery - An effective triumvirate of pharmacosomes.
Kapoor B; Gupta R; Singh SK; Gulati M; Singh S
Adv Colloid Interface Sci; 2018 Mar; 253():35-65. PubMed ID: 29454464
[TBL] [Abstract][Full Text] [Related]
13. Lipid-Based Nanovesicular Drug Delivery Systems.
Limongi T; Susa F; Marini M; Allione M; Torre B; Pisano R; di Fabrizio E
Nanomaterials (Basel); 2021 Dec; 11(12):. PubMed ID: 34947740
[TBL] [Abstract][Full Text] [Related]
14. Vesicular Nanocarriers: A Potential Platform for Topical/Transdermal Delivery of Antibiotics.
Chadha M; Malik DS
Recent Pat Nanotechnol; 2024 Jan; ():. PubMed ID: 38204233
[TBL] [Abstract][Full Text] [Related]
15. Vesicular Systems Containing Curcumin and Their Applications in Respiratory Disorders - A Mini Review.
Chellappan DK; Hansbro PM; Dua K; Hsu A; Gupta G; Ng ZY; Wong JY; Chellian J; Panneerselvam J
Pharm Nanotechnol; 2017; 5(4):250-254. PubMed ID: 28786351
[TBL] [Abstract][Full Text] [Related]
16. Site-Specific Vesicular Drug Delivery System for Skin Cancer: A Novel Approach for Targeting.
Pandey M; Choudhury H; Gorain B; Tiong SQ; Wong GYS; Chan KX; They X; Chieu WS
Gels; 2021 Nov; 7(4):. PubMed ID: 34842689
[TBL] [Abstract][Full Text] [Related]
17. Overcoming Skin Barrier with Transfersomes: Opportunities, Challenges, and Applications.
Dixena B; Madhariya R; Panday A; Ram A; Jain AK
Curr Drug Deliv; 2024 Jan; ():. PubMed ID: 38178667
[TBL] [Abstract][Full Text] [Related]
18. Niosomes: a controlled and novel drug delivery system.
Rajera R; Nagpal K; Singh SK; Mishra DN
Biol Pharm Bull; 2011; 34(7):945-53. PubMed ID: 21719996
[TBL] [Abstract][Full Text] [Related]
19. Liposome-Derived Nanosystems for the Treatment of Behavioral and Neurodegenerative Diseases: The Promise of Niosomes, Transfersomes, and Ethosomes for Increased Brain Drug Bioavailability.
Pires PC; Paiva-Santos AC; Veiga F
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895895
[TBL] [Abstract][Full Text] [Related]
20. Aquasomes: Advanced Vesicular-based Nanocarrier Systems.
Kulkarni S; Prabhakar B; Shende P
Curr Pharm Des; 2022; 28(29):2404-2414. PubMed ID: 35909274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
